Search
for
Sort by
Research 30 of 1000+
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Novel acne cream seeks FDA approval
- FDA declines approval of testosterone drug for third time
- FDA declines approval of testosterone drug for third time
- Shedding light on the FDA’s 510(k) approvals process: low-level laser therapy devices used in the treatment of androgenetic alopecia
- Fast-tracked innovation: orforglipron approval under the FDA’s National Priority Voucher program
- Retrospective Pharmacotherapeutic Evaluation of Dutasteride not Approved by US FDA for Androgenetic Alopecia in Korea
- Low‐level laser (light) therapy (LLLT) for treatment of hair loss
- Alopecia Areata: An Updated Review for 2023
- Exosomes in Cosmetic Dermatology: A Review of Benefits and Challenges
- LASER HAIR TRANSPLANTATION
- Practical Geriatrics: Maintaining Sexual Health After Menopause
- Hidradenitis suppurativa encounters in a national electronic health record database notable for low dermatology utilization, infrequent biologic prescriptions, and frequent opiate prescriptions
- Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
- Regulatory, Ethical, and Safety Considerations of Exosome‐Based Therapies in Dermatology
- Public Interest in Janus Kinase (JAK) IInhibitors for Alopecia Areata: A Google Trend Analysis
- Public Interest in JAK Inhibitors for Alopecia Areata: A Google Trend Analysis (Preprint)
- Can oral minoxidil be the game changer in androgenetic alopecia? A comprehensive review and meta-analysis comparing topical and oral minoxidil for treating androgenetic alopecia
- Robotically assisted follicular unit extraction in surgical hair restoration
- Photographic Imaging in Hair Loss
- Finasteride toxicity information: “limited”, “poor quality”, “biased”
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- FDA Approved pediatric antihypertensive agents
- Dutasteride for Androgenetic Alopecia—Words of Caution
- ‘Ritlecitinib: unveiling hair regrowth for alopecia areata’
- Alopecia areata: current concepts
- Preparation and Evaluation of Matruj SBA Hair Oil Containing Polyherbs for Arresting Hair Problems
- La FDA aprueba Litfulo® (ritlecitinib) para el tratamiento de la alopecia areata grave en adolescentes y adultos
- FDA approves label addition for PDE-5 inhibitor
- 448 Challenges of securing insurance approval for oral tofacitinib treatment of alopecia areata: A multi-institutional retrospective review